Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2012
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tarazi Antoine E, Al-Tawfiq Jaffar A, Abdi Rifat F
Аннотация
HYPOTHESIS: Oral voriconazole is a viable alternative modality treatment to traditionally used intravenous vancomycin in the treatment of malignant otitis externa (MOE).
BACKGROUND: The incidence of MOE is on the rise, more so in Saudi Arabia where diabetes mellitus is endemic. Although Pseudomonas aeruginosa is the most common offending organism, we are observing an increasing number of fungal MOE, in particular, Aspergillus species. The clinical findings in these patients can be quite different from those of the classic gram-negative bacteria.
METHODS: Chart review of patients with a diagnosis of MOE who underwent oral voriconazole treatment.
RESULTS: Three cases of Aspergillus MOE are reported in detail, pointing the pitfalls in clinical findings, diagnosis, and management of this entity.
CONCLUSION: Oral voriconazole proved to be an excellent alternative modality treatment in this population of patients with MOE.
BACKGROUND: The incidence of MOE is on the rise, more so in Saudi Arabia where diabetes mellitus is endemic. Although Pseudomonas aeruginosa is the most common offending organism, we are observing an increasing number of fungal MOE, in particular, Aspergillus species. The clinical findings in these patients can be quite different from those of the classic gram-negative bacteria.
METHODS: Chart review of patients with a diagnosis of MOE who underwent oral voriconazole treatment.
RESULTS: Three cases of Aspergillus MOE are reported in detail, pointing the pitfalls in clinical findings, diagnosis, and management of this entity.
CONCLUSION: Oral voriconazole proved to be an excellent alternative modality treatment in this population of patients with MOE.